Skip to content

Bicyclic Peptide Inhibitors of the Human Urokinase-Type Plasminogen Activator (HUPA)

These bicyclic peptides can detect the urokinase-type plasminogen activator (huPA) and inhibit its cell degeneration action (TRL2/3)

Published: 19th July 2022
Bicyclic Peptide Inhibitors of the Human Urokinase-Type Plasminogen Activator (HUPA)
irinad85, https://stock.adobe.com/uk/409310000, stock.adobe.com
Patents
  • 102022000012431
IP Status
  • Patent application submitted
  • Know-how based
Seeking
  • Development partner
  • Licensing
  • University spin out
  • Seeking investment